
The Point-Of-Care diagnosis has become a promising strategy
Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, growing government support, and rising preference for home
A Lab with assay functions is minimized to half the size of credit card
Multiple flows of preloaded reagent are programmed to achieve an automated test
A microscopic array of pathogenic biomarkers and antibodies is used to pinpoint panel of target diseases
Lock and key nature of immunoassay fluorescence contributes highly specific signal
Next Generation Rapid Diagnostic Platform
Learn how we are revolutionizing the diagnostic landscape with ALiA®, an end-to-end testing solution that delivers multiple results with only one drop of sample in 15 minutes.
COVID-19 Rapid Antigen Test
Get reliable results with CO-Check COVID-19 Antigen test in 15 minutes.
Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, growing government support, and rising preference for home
ALiA is developed as an end-to-end Point-of-Care Testing (POCT) platform with digital healthcare management solutions for combating time-critical and life-threatening diseases and outbreaks. Come and visit
Today is the 2nd day of The Hong Kong International Medical and Healthcare Fair 2022 @HKCEC. We are pleased to introduce our transformative Point-Of-Care Testing
Address: Unit 2, 5/F, Wah Lai Industrial Centre, 10 – 14 Kwei Tei Street, Fo Tan, Hong Kong
Tel: + 852 2698 9903
Fax: +852 3619 5770